New study tracks how a drug combo affects liver function in advanced cancer patients
NCT ID NCT07607769
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This study is observing 200 adults with advanced liver cancer who are starting a new treatment with two drugs, tremelimumab and durvalumab. Researchers want to see how long it takes for liver problems to get worse, how patients feel, and how safe the treatment is in everyday medical practice. Participants must have good liver function at the start and not have had other cancer treatments before.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGAncona, Italy
-
Research Site
RECRUITINGBergamo, Italy
-
Research Site
RECRUITINGFoggia, Italy
-
Research Site
RECRUITINGMeldola, Italy
-
Research Site
RECRUITINGMilan, Italy
-
Research Site
NOT_YET_RECRUITINGModena, Italy
-
Research Site
RECRUITINGNaples, Italy
-
Research Site
RECRUITINGPadova, Italy
-
Research Site
RECRUITINGPalermo, Italy
-
Research Site
RECRUITINGPisa, Italy
-
Research Site
RECRUITINGPozzuoli, Italy
-
Research Site
RECRUITINGRoma, Italy
-
Research Site
RECRUITINGRozzano, Italy
-
Research Site
RECRUITINGTorino, Italy
-
Research Site
NOT_YET_RECRUITINGVerona, Italy
-
Research site
ACTIVE_NOT_RECRUITINGAncona, 60126, Italy
-
Research site
RECRUITINGFoggia, 71122, Italy
-
Research site
ACTIVE_NOT_RECRUITINGMilan, 20122, Italy
-
Research site
ACTIVE_NOT_RECRUITINGModena, 41124, Italy
-
Research site
RECRUITINGNaples, 80131, Italy
-
Research site
ACTIVE_NOT_RECRUITINGPozzuoli, 80078, Italy
-
Research site
ACTIVE_NOT_RECRUITINGRozzano, 20089, Italy
-
Research site
ACTIVE_NOT_RECRUITINGTorino, 10126, Italy
-
Research site
ACTIVE_NOT_RECRUITINGVerona, 37134, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?